Acute Heart Failure
Conditions
Keywords
therapeutic education
Brief summary
The observatory consists of a row of data collection on a population composed of all patients with heart failure cared for in centers participating in the national education program for patients (named I-CARE) in the form of two groups. Patients who are undergoing a program of therapeutic education track are listed and included in the group of patients educated. Patients who receive no education or only a minimal element for any reason whatsoever are also listed and included in the group of patients who are not educated. The following of patients will be periodic after their entry in the observatory, up to 2 years of follow up.
Detailed description
The Center for patients with heart failure cared for in a center practicing therapeutic education dedicated to heart failure. The definition of heart failure selected for inclusion is that recommended by the European Society of Cardiology : presence of at least two signs or symptoms of heart failure (dyspnea, edema of the ankles crackles) at rest or during exercise associated with objective evidence (preferably by echocardiography) of cardiac dysfunction ( systolic and / or diastolic) (resting) and in case of doubt, a response to specific treatment of heart failure. All patients who are undergoing a program of therapeutic education track are listed and included in the group of patients educated. All patients who receive no education or only a minimal element for any reason whatsoever are also listed and included in the group of patients who are not educated. Follow up is done by CRAs at the French Society of Cardiology, by mailing and phone contacts.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient with heart failure * Patient supported by a center participating in the I-CARE french program
Exclusion criteria
* Refusal by the patient to be listed in an observatory
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Event-free survival | 2 years | To analyse survival after 2 years of follow-up (all-causes death) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Recurrence of heart failure | 2 years | Analyze the data of disease: recurrence of heart failure |
| Therapeutic | 2 years | Analyze the data of disease: therapeutic took 2 years of follow-up |
| Number of participants with adverse events | 2 years | Analyze the data of disease: cardiovascular events or other non-cardiovascular |
Countries
France